Home   About this service   Get the news  
+32 2 743 34 03

UCB [BE0003739530 / UCB]

UCB Media Room: Transparency Notification


[07/01/2020 | 20:01]

** Transparency notification BlackRock, Inc.

=C2=B7 Notification referring to situation on 31 December 2019
=C2=B7 Threshold crossed: 5%
=C2=B7 Latest holding: 5.04%=C2=A0

Brussels (Belgium), 7 January 2020 =E2=80=93 20:00 (CET) =E2=80=93 regulate=
d information

1.=C2=A0=C2=A0Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB SA/NV announces that it has received a transparency noti=
fication from BlackRock, Inc. (having its registered office at 55 East 52nd=
Street, New York, NY, 10055, U.S.A.), dated 2 January 2020.

BlackRock, Inc., has notified that, following a disposal of UCB shares with=
voting rights by its affiliates, its holding of UCB shares with voting rig=
hts has decreased and has crossed downwards the 5% threshold on 31 December=

On 31 December 2019, BlackRock, Inc. (taking into account the holding of it=
s affiliates) Inc. owned 9 647 211 UCB shares with voting rights (versus 9 =
735 421 shares in its previous notification), representing 4.96% of the tot=
al number of shares issued by the company (194 505 658) (versus 5.01% in it=
s previous notification), as well as 150 268 equivalent financial instrumen=
ts (versus 198 312 in its previous notification) representing 0.08% of the =
total number of shares issued by the company (versus 0.10% in its previous =

2.=C2=A0=C2=A0Content of the notification

=C2=B7 Reason for the notification: Acquisition or disposal of voting secur=
ities or voting rights.=C2=A0
=C2=B7 Notification by: A parent undertaking or a controlling person.
=C2=B7 Persons subject to the notification requirement:=C2=A0


=C2=B7 Date on which the threshold is crossed: 31 December 2019.
=C2=B7 Threshold crossed (in %): 5%
=C2=B7 Denominator: 194 505 658.
=C2=B7 Notified details:



=C2=B7 Chain of controlled undertakings through which the holding is effect=
ively held:

Please see the full chain of control in the =E2=80=98Chain of Control=E2=80=
=99 tab.

=C2=B7 Additional information:=C2=A0

The disclosure obligation arose due to voting rights attached to shares for=
BlackRock, Inc. going below 5%.=C2=A0

3.=C2=A0=C2=A0Further information=C2=A0

This press release and the detailed transparency notification are available=
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com=
/investors/UCB-shareholders) .

An updated overview of the UCB SA/NV large shareholdings will be available =
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com/=
investors/UCB-shareholders) .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i=
n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
Capture 1 Transparency Jan 7 2020 (https://mb.cision.com/Public/18595/30028=
58/a4e7db5e9110cce5_org.jpg) Image
Capture 2 Transparency Jan 7 2020 (https://mb.cision.com/Public/18595/30028=
58/bc2c0955c0eb0b59_org.jpg) Image
Capture 3 Transparency Jan 7 2020 (https://mb.cision.com/Public/18595/30028=
58/92b353e8d52ce20c_org.jpg) GenericFile
200107-Transparency notification press release Blackrock (https://mb.cision=
.com/Public/18595/3002858/ae1b742fd03d20c5.pdf) GenericFile
200107- Notification de transparence comm de presse Blackrock (https://mb.c=
ision.com/Public/18595/3002858/82dd1094dbb9bea8.pdf) GenericFile
200107-Transparantieverklaring persbericht Blackrock (https://mb.cision.com=
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x32990x1x6868579x24000=
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=